Characterization of miRNomes in Acute and Chronic Myeloid Leukemia Cell Lines

详细信息    查看全文

• 作者：Qian Xiong¹ ; ² ; ^# ; Yadong Yang¹ ; ^# ; Hai Wang¹ ; Jie Li¹ ; ² ; Shaobin Wang¹ ; Yanming Li¹ ; ² ; Yaran Yang¹ ; Kan Cai¹ ; Xiuyan Ruan¹ ; Jiangwei Yan¹ ; Songnian Hu¹ ; ^{husn@big.ac.cn" class="auth_mail} ; Xiangdong Fang¹ ; ^{fangxd@big.ac.cn" class="auth_mail}
• 关键词：miRNA profiling ; Acute myeloid leukemia ; Chronic myeloid leukemia ; Myeloid differentiation
• 刊名：Genomics, Proteomics Bioinformatics
• 出版年：April 2014
• 年：2014
• 卷：12
• 期：2
• 页码：79-91
• 全文大小：1040 K

文摘

Myeloid leukemias are highly diverse diseases and have been shown to be associated with microRNA (miRNA) expression aberrations. The present study involved an in-depth miRNome analysis of two human acute myeloid leukemia (AML) cell lines, HL-60 and THP-1, and one human chronic myeloid leukemia (CML) cell line, K562, via massively parallel signature sequencing. mRNA expression profiles of these cell lines that were established previously in our lab facilitated an integrative analysis of miRNA and mRNA expression patterns. miRNA expression profiling followed by differential expression analysis and target prediction suggested numerous miRNA signatures in AML and CML cell lines. Some miRNAs may act as either tumor suppressors or oncomiRs in AML and CML by targeting key genes in AML and CML pathways. Expression patterns of cell type-specific miRNAs could partially reflect the characteristics of K562, HL-60 and THP-1 cell lines, such as actin filament-based processes, responsiveness to stimulus and phagocytic activity. miRNAs may also regulate myeloid differentiation, since they usually suppress differentiation regulators. Our study provides a resource to further investigate the employment of miRNAs in human leukemia subtyping, leukemogenesis and myeloid development. In addition, the distinctive miRNA signatures may be potential candidates for the clinical diagnosis, prognosis and treatment of myeloid leukemias.